News
-
The European Commission (EC) has approved MedImmune’s Fluenz Tetra intranasal four-strain live attenuated influenza vaccine for the prevention of flu in children aged 24 months to 18 years, parent company AstraZeneca has announced. Fluenz Tetra… Read more . . .
-
Marinomed Biotechnologie has announced that a randomized, double-blind placebo-controlled study of more than 200 patients suffering from the common cold found that patients who received a Carragelose-based nasal spray reduced the duration of symptoms by… Read more . . .
-
GlaxoSmithKline and Theravance have announced that a 12-week double-blind, parallel group Phase 3 study of their fluticasone furoate (FF)/vilanterol (VI) DPI (Breo/Relvar Ellipta) in almost 1,000 patients with moderate to severe asthma met its primary… Read more . . .
-
Spanish pharmaceutical company Almirall has issued a statement saying that the company will “reorganize” its European operations as a result of “economic driven decisions, made by country’s health authorities that have negatively affected the growth… Read more . . .
-
Hovione has announced that the addition of a MG2 FlexaLAB capsule filling machine will allow the company to expand its inhalation drug product development services. The FlexaLAB can fill up to 3,000 capsules per hour… Read more . . .
-
A study by the Cochrane Acute Respiratory Infections Group examined data from four studies involving almost 2,000 patients with acute sinusitis and determined that the benefits of intranasal corticosteroids (INCS) are “modest but clinically important.”… Read more . . .
-
Going to DDL 24 in Edinburgh next week? Gateway Analytical is inviting meeting attendees to a V.I.P. event at The Scotch Whisky Experience on the evening of December 11. The event includes a tour and… Read more . . .
-
According to Lightlake Therapeutics, initial results from a two-week PK study of intranasal naloxone for the treatment of opioid overdose shows that the nasal spray gets naloxone into the bloodstream as fast as injection. The… Read more . . .
-
Taiwan’s FDA has canceled marketing authorizations for calcitonin nasal sprays effective December 1 2013, and the products must be recalled within two months. According to the China Post, calcitonin nasal spray was first licensed in… Read more . . .
-
According to Bespak parent company Consort Medical, Bespak will construct a new dedicated facility at it’s King’s Lynn, UK site in order to meet production demands after signing a contract to manufacture a proprietary dry… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.